Pediatric Thyroid Cancer: Genetics, Therapeutics and Outcome.

An increasing number of children are diagnosed with thyroid cancer. Most patients do not have an identifiable cause; however, tumor predisposition syndromes may be associated with development of both differentiated and medullary thyroid cancer. With an excellent prognosis for most patients, the goal of therapy is to optimize outcome and reduce complications. The increased knowledge of the oncogenic drivers provides opportunities to improve the accuracy of diagnosis, stratify surgery, and select systemic therapy that may be considered for neoadjuvant and adjuvant treatment. Treatment complications can be reduced by referral to regional, high-volume pediatric thyroid centers.
Competing Interests: Disclosure The author has no financial disclosures that affect the content of this article. The author has received an honorarium from Hexal AG to review abstracts for EndoToday (2019).
(Copyright © 2020 Elsevier Inc. All rights reserved.)